Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
01 1FARMAK, a.s
02 1Biophore India Pharmaceuticals Pvt Ltd
03 1USV Private Limited
04 1Anax Laboratories
05 1BrightGene Bio-Medical Technology Co.,Ltd
06 1Curia
07 2GLAND PHARMA LIMITED
08 1Hetero Drugs
09 1MSN Laboratories
10 1Nanjing Heron Pharmaceutical
11 1SKVen Technologies Pvt. Ltd
12 1ScinoPharm Taiwan, Ltd
13 1Sionc Pharmaceuticals
14 1Sun Pharmaceutical Industries Limited
15 1Viatris
16 1Wockhardt
17 1Zhuhai Rundu Pharmaceutical
01 3China
02 1Czech Republic
03 11India
04 1Taiwan
05 2U.S.A
01 12Active
02 6Blank
01 18Blank
01 18Blank
01 1WC-0273
02 1WC-0427
03 16Blank
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-02-18
Pay. Date : 2021-01-13
DMF Number : 35433
Submission : 2021-01-04
Status : Active
Type : II
NDC Package Code : 63278-1068
Start Marketing Date : 2010-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-12-08
Pay. Date : 2016-09-16
DMF Number : 30834
Submission : 2016-09-13
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-08-24
Pay. Date : 2015-06-24
DMF Number : 29315
Submission : 2015-06-23
Status : Active
Type : II
NDC Package Code : 62147-0220
Start Marketing Date : 2019-12-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-12-08
Pay. Date : 2017-03-27
DMF Number : 31539
Submission : 2017-11-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36679
Submission : 2022-01-24
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-15
Pay. Date : 2014-02-27
DMF Number : 27972
Submission : 2014-02-12
Status : Active
Type : II
Date of Issue : 2019-03-05
Valid Till : 2022-03-04
Written Confirmation Number : WC-0427
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36338
Submission : 2021-11-26
Status : Active
Type : II
NDC Package Code : 69766-103
Start Marketing Date : 2021-11-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-10-16
Pay. Date : 2015-08-27
DMF Number : 28939
Submission : 2014-12-25
Status : Active
Type : II
NDC Package Code : 65129-1331
Start Marketing Date : 2015-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-09-30
Pay. Date : 2015-03-31
DMF Number : 29185
Submission : 2015-03-31
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-12-04
Pay. Date : 2018-09-14
DMF Number : 32339
Submission : 2018-01-07
Status : Active
Type : II
We have 17 companies offering Regadenoson Monohydrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?